Legend Biotech Corporation · Biotechnology

LEGNLegend Biotech Corporation

Reports 2026-11-10 Pre-market · TueReaction day 11-10upcoming

Before the print · expectations18 days to the print

Street consensus

$0.01EPS

$369MRevenue

No past prints on file yet.

What the record doesn't tell you

Which way does LEGN go on 11‑10?

Model lean for 11-10, and the evidence behind it
Move band, P10 – P90
Last 8 prints, quarter by quarter
Peers that already reported, and how they traded

Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-10 · Pre-market

Revenue—

est. $369M

EPS—

est. $0.01

Guidance—read from the 8-K once filed

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Legend Biotech earnings preview: what the record says

Legend Biotech (LEGN) is scheduled to report earnings on Nov 10, 2026, before the open. The consensus estimate calls for EPS of $0.01 on revenue of $369M.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

LEGN earnings: key questions

When is LEGN's next earnings date?

Legend Biotech is scheduled to report on Nov 10, 2026, before the open.

What are LEGN's earnings expectations?

Analysts expect EPS of $0.01 on revenue of $369M for the quarter.